Elan News
Most Popular Elan Story
Elan's Martin: Worst biotech CEO?
Elan's CEO Kelly Martin (photo) has the dubious honor of being picked as The Street's worst biotech CEO of 2008. Biotech writer Adam Feuerstein slams Martin for talking up the experimental... Read more...
Latest Headlines
- December 15, 2009
- August 3, 2009
- June 29, 2009
- June 3, 2009
- May 13, 2009
- April 22, 2009
- April 2, 2009
- March 26, 2009
- February 25, 2009
- January 13, 2009
- December 12, 2008
- December 10, 2008
- November 20, 2008
- October 15, 2008
- August 27, 2008
- August 21, 2008
- July 21, 2008
- June 17, 2008
- June 16, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
